TABLE 2.
Time to Diagnosis, Median (IQR), d | P | Time to Treatment, Median (IQR), d | P | Time From Imaging to Treatment, Median (IQR), d | P | Time From Diagnosis to Treatment, Median (IQR), d | P | |
---|---|---|---|---|---|---|---|---|
Race/ethnicity | .54 | .23 | .09 | .13 | ||||
Asian/Pacific Islander | 13 (6–40) | 30 (11–57) | 31 (14–45) | 7 (0–18) | ||||
Hispanic | 20 (10–35) | 34 (19–60) | 25 (12–44) | 8 (2–21) | ||||
American Indian | 15 (12–27) | 36 (24–49) | 29 (17–41) | 21 (4–31) | ||||
Non-Hispanic Black | 20 (10–36) | 35 (19–57) | 28 (14–48) | 10 (2–21) | ||||
Non-Hispanic White | 19 (10–31) | 31 (19–49) | 25 (14–41) | 8 (0–19) | ||||
Unknown | 22 (17–33) | 28 (23–60) | 27 (14–49) | 11 (2–21) | ||||
Pathologic diagnosis | .68 | .98 | .66 | .45 | ||||
Atypia | 18 (12–37) | 34 (16–57) | 28 (14–47) | 9 (0–19) | ||||
Malignancy | 20 (10–33) | 33 (19–54) | 26 (14–44) | 8 (1–21) | ||||
Age | <.001 | <.001 | <.001 | .14 | ||||
<50 y | 18 (8–30) | 30 (17–48) | 24 (12–40) | 8 (0–19) | ||||
≥50 y | 21 (11–36) | 35 (20–58) | 28 (15–48) | 9 (2–21) | ||||
Funding | <.001 | <.001 | <.001 | .001 | ||||
Fully funded | 21 (12–36) | 35 (20–57) | 26 (13–43) | 8 (0–21) | ||||
Partially funded | 19 (10–32) | 34 (20–52) | 29 (19–48) | 12 (3–21) | ||||
Not funded | 12 (5–22) | 22 (12–38) | 18 (10–34) | 7 (2–15) |
Abbreviation: IQR, interquartile range.